First Time Loading...

Danaher Corp
NYSE:DHR

Watchlist Manager
Danaher Corp Logo
Danaher Corp
NYSE:DHR
Watchlist
Price: 265.32 USD 0.18% Market Closed
Updated: May 18, 2024

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Danaher Corp

Revenue
43.7B USD
Cost of Revenue
-18.2B USD
Gross Profit
25.6B USD
Operating Expenses
-16.1B USD
Operating Income
9.5B USD
Other Expenses
-1.4B USD
Net Income
8.1B USD

Margins Comparison
Danaher Corp Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Danaher Corp
NYSE:DHR
196.5B USD
58%
22%
18%
US
Thermo Fisher Scientific Inc
NYSE:TMO
230.2B USD
40%
17%
14%
US
Agilent Technologies Inc
NYSE:A
45.2B USD
51%
19%
18%
US
IQVIA Holdings Inc
NYSE:IQV
42.1B USD
35%
14%
9%
CH
Lonza Group AG
SIX:LONN
38.2B CHF
36%
20%
10%
KR
Samsung Biologics Co Ltd
KRX:207940
56.1T KRW
49%
30%
23%
US
Mettler-Toledo International Inc
NYSE:MTD
32.4B USD
59%
29%
21%
IE
ICON PLC
NASDAQ:ICLR
26B USD
30%
13%
8%
US
West Pharmaceutical Services Inc
NYSE:WST
26B USD
37%
23%
19%
US
Waters Corp
NYSE:WAT
21.1B USD
60%
27%
21%
FR
Sartorius Stedim Biotech SA
PAR:DIM
18.3B EUR
43%
15%
9%
Country US
Market Cap 196.5B USD
Gross Margin
58%
Operating Margin
22%
Net Margin
18%
Country US
Market Cap 230.2B USD
Gross Margin
40%
Operating Margin
17%
Net Margin
14%
Country US
Market Cap 45.2B USD
Gross Margin
51%
Operating Margin
19%
Net Margin
18%
Country US
Market Cap 42.1B USD
Gross Margin
35%
Operating Margin
14%
Net Margin
9%
Country CH
Market Cap 38.2B CHF
Gross Margin
36%
Operating Margin
20%
Net Margin
10%
Country KR
Market Cap 56.1T KRW
Gross Margin
49%
Operating Margin
30%
Net Margin
23%
Country US
Market Cap 32.4B USD
Gross Margin
59%
Operating Margin
29%
Net Margin
21%
Country IE
Market Cap 26B USD
Gross Margin
30%
Operating Margin
13%
Net Margin
8%
Country US
Market Cap 26B USD
Gross Margin
37%
Operating Margin
23%
Net Margin
19%
Country US
Market Cap 21.1B USD
Gross Margin
60%
Operating Margin
27%
Net Margin
21%
Country FR
Market Cap 18.3B EUR
Gross Margin
43%
Operating Margin
15%
Net Margin
9%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Danaher Corp Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Danaher Corp
NYSE:DHR
196.5B USD
16%
10%
12%
10%
US
Thermo Fisher Scientific Inc
NYSE:TMO
230.2B USD
13%
6%
9%
8%
US
Agilent Technologies Inc
NYSE:A
45.2B USD
21%
11%
14%
14%
US
IQVIA Holdings Inc
NYSE:IQV
42.1B USD
23%
5%
10%
9%
CH
Lonza Group AG
SIX:LONN
38.2B CHF
7%
4%
9%
8%
KR
Samsung Biologics Co Ltd
KRX:207940
56.1T KRW
9%
5%
9%
6%
US
Mettler-Toledo International Inc
NYSE:MTD
32.4B USD
-849%
23%
48%
28%
IE
ICON PLC
NASDAQ:ICLR
26B USD
8%
4%
8%
6%
US
West Pharmaceutical Services Inc
NYSE:WST
26B USD
21%
16%
22%
20%
US
Waters Corp
NYSE:WAT
21.1B USD
69%
15%
26%
20%
FR
Sartorius Stedim Biotech SA
PAR:DIM
18.3B EUR
8%
4%
7%
5%
Country US
Market Cap 196.5B USD
ROE
16%
ROA
10%
ROCE
12%
ROIC
10%
Country US
Market Cap 230.2B USD
ROE
13%
ROA
6%
ROCE
9%
ROIC
8%
Country US
Market Cap 45.2B USD
ROE
21%
ROA
11%
ROCE
14%
ROIC
14%
Country US
Market Cap 42.1B USD
ROE
23%
ROA
5%
ROCE
10%
ROIC
9%
Country CH
Market Cap 38.2B CHF
ROE
7%
ROA
4%
ROCE
9%
ROIC
8%
Country KR
Market Cap 56.1T KRW
ROE
9%
ROA
5%
ROCE
9%
ROIC
6%
Country US
Market Cap 32.4B USD
ROE
-849%
ROA
23%
ROCE
48%
ROIC
28%
Country IE
Market Cap 26B USD
ROE
8%
ROA
4%
ROCE
8%
ROIC
6%
Country US
Market Cap 26B USD
ROE
21%
ROA
16%
ROCE
22%
ROIC
20%
Country US
Market Cap 21.1B USD
ROE
69%
ROA
15%
ROCE
26%
ROIC
20%
Country FR
Market Cap 18.3B EUR
ROE
8%
ROA
4%
ROCE
7%
ROIC
5%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More